In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Cancer Type/Condition:  Soft tissue sarcoma, adult
Stage/Subtype:  stage II adult soft tissue sarcoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-62092-22092, EORTC-62092, EORTC-22092, EU-21113, STRASS, NCT01344018

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000628781, UCDCC-216, BAYER-UCDCC-216, NCT00805727

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-104, NCT01418001

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 12-100, NCT01659203

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VCC 1202, NCT01719302

6.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 25 and under for new enrollments only
Sponsor: Other
Protocol IDs: RTSARC, NCT00186992

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 05-090, 1 R21 CA117128-01A1, NCT00356031

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: 05-326, Other, NCT00592293

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 04-188, P01CA021239, NCT00592592

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 09510, NCT01561495

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 5120263, NCT01819831

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 9464, NCI-2013-02414, P30CA069533, NCT02050919

13.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AAAD4523, NCT01010958

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and over
Sponsor: Other
Protocol IDs: 09-090, NCT01099644

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 191511, NCI-2011-03568, P30CA016056, NCT01522820

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-396, NCT01746238

17.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 29
Sponsor: Other
Protocol IDs: 10-091, NCT01189643

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 7487, NCI-2011-02488, P30CA015704, NCT01446809

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 229812, NCI-2013-01198, P30CA016056, NCT01896778

20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2705.00, NCI-2013-01779, K12CA076930, P30CA015704, NCT01957709
New Search